Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kdd999 who wrote (360)	12/10/2007 10:28:36 PM
From: buffalodon2003	Read Replies (1) of 370

I agree with the selloff. Imo, the new purchases at the .56 - .65 pps made a nice profit and would be smart to sell. That was a great buy on the eve of ASH and Phase II PR coming out in the forefront. It seems that stocks rise just prior to trial data at these conferences, despite VION's fall to down .03 by day's end. I think we settle here and slowly rise to $1.00 - 1.10 at end of 1st quarter. I am a little confused about this stock though. I've acquired various times starting 2 - 3 years ago and would have thought it's conservative high would have hit $3/share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next